Particulate Matter in Injectables: Regulatory Requirements, USP 788 Limits & GMP Compliance Guide
Particulate Matter in Injectables: USP <788> Limits, Regulatory Requirements & GMP Compliance Guide Table of Contents 1. Introduction – Why Particulate Matter is a Critical Risk 2. Scientific Principle of Particulate Testing 3. Procedure Overview (USP <788> Methods) 4. Scientific Rationale & Risk Justification 5. Regulatory Requirements (USP, EP, IP, PDA, GMP) 6. Practical Examples & Failure Scenarios 7. Failure Avoidance Strategies 8. Common Audit Observations 9. FAQs 10. Summary & Conclusion 1. Introduction – Why Particulate Matter is a Critical Risk Particulate matter in injectable products is one of the most frequently cited regulatory observations in sterile manufacturing. Unlike microbial contamination , visible and sub-visible particles can directly enter systemic circulation, posing embolic, inflammatory, and immunogenic risks to patients. Regulatory agencies require strict compliance with USP <788> Particulate Matter in...